The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer
Open accessPublished version of a preprint
Abstract
Metastasis to distant tissues is the chief driver of breast cancer–related mortality, but little is known about the systemic physiologic dynamics that regulate this process. To investigate the role of neuroendocrine activation in cancer progression, we used in vivo bioluminescence imaging to track the development of metastasis in an orthotopic mouse model of breast cancer. Stress-induced neuroendocrine activation had a negligible effect on growth of the primary tumor but induced a 30-fold increase in metastasis to distant tissues including the lymph nodes and lung. These effects were mediated by β-adrenergic signaling, which increased the infiltration of CD11b+F4/80+ macrophages into primary tumor parenchyma and thereby induced a prometastatic gene expression signature accompanied by indications of M2 macrophage differentiation. Pharmacologic activation of β-adrenergic signaling induced similar effects, and treatment of stressed animals with the β-antagonist propranolol reversed the stress-induced macrophage infiltration and inhibited tumor spread to distant tissues. The effects of stress on distant metastasis were also inhibited by in vivo macrophage suppression using the CSF-1 receptor kinase inhibitor GW2580. These findings identify activation of the sympathetic nervous system as a novel neural regulator of breast cancer metastasis and suggest new strategies for antimetastatic therapies that target the β-adrenergic induction of prometastatic gene expression in primary breast cancers. Cancer Res; 70(18); 7042–52. ©2010 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the context of metastatic breast cancer, for example, stress effects on tumor metastasis are mediated by β-adrenergic up-regulation of monocytes and macrophages within the tumor microenvironment [44] (i.e., the same dynamic that drives the CTRA transcriptome shift in circulating blood [9]).”
From Human Social Genomics (2014) · cites this paper as [44]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, Sloan et al. found that both stress-induced and pharmacological β-adrenergic stimulation promoted macrophage migration into tumor tissue in a mouse model of breast cancer. These macrophages then adopted an immunosuppressive M2 phenotype, leading to increased production of TGF-β, VEGF, and MMP-9, which in turn promoted angiogenesis and metastasis.322”
From Drug repurposing for cancer therapy (2024) · cites this paper as [322]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Parallel findings in animal and in vitro models support these data [11, 16–22].”
From Living Well: Protocol for a web-based program to improve quality of life in rural and urban ovarian cancer survivors (2024) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“Parallel effects have been observed in experimental animal models of cancer, and those analyses again identify a prominent role for SNS activation of β-adrenergic signaling [43], [44].”
From Human Social Genomics (2014) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,603
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,414
Ferguson, S. S. G. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01478-9 · Cited by 1,827
DeNardo, D. G., Barreto, J., Andreu, P., Vásquez, L. J., Tawfik, D., Kolhatkar, N. S., & Coussens, L. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.018 · Cited by 1,395
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., et al. (2006) · Nature Medicine · doi:10.1038/nm1447 · Cited by 1,320
Self-citationDo stress-related psychosocial factors contribute to cancer incidence and survival?
Chida, Y., Hamer, M., Wardle, J., & Steptoe, A. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1134 · Cited by 1,072
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms
Antoni, M. H., Lutgendorf, S. K., Cole, S. W., Dhabhar, F. S., Sephton, S. E., McDonald, P. G., Stefanek, M., & Sood, A. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1820 · Cited by 981
Self-citationSocial networks, social support, and survival after breast cancer diagnosis
Kroenke, C. H., Kubzansky, L. D., Schernhammer, E. S., Holmes, M. D., & Kawachi, I. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2846 · Cited by 792
Catecholamine Influences and Sympathetic Neural Modulation of Immune Responsiveness
Madden, K. S., Sanders, V. M., & Felten, D. L. (1995) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.002221 · Cited by 441
Cited by
Sorted by citations
Items 401–500 of 928
The biology and engineered modeling strategies of cancer-nerve crosstalk
Gregory, E., Dugan, R., David, G., & Song, Y. H. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188406 · Cited by 22
Neuroimmune Regulation of Surgery-Associated Metastases
Shurin, M. R., Baraldi, J. H., & Shurin, G. V. (2021) · Cells · doi:10.3390/cells10020454 · Cited by 24
Shaashua, L., Rosenne, E., Neeman, E., Sorski, L., Sominsky, L., Matzner, P., Page, G. G., & Ben‐Eliyahu, S. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.12.001 · Cited by 24
Abdin, A. A., Soliman, N. A., & Saied, E. M. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.07.010 · Cited by 24
Stressful Life Events and Risk of Colorectal Cancer: A Case-Control Study of Iran
Azizi, H., & Esmaeili, E. D. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.6.2403 · Cited by 24
Neural regulation of cancer: from mechanobiology to inflammation
Kim, T. P., Rowat, A. C., & Sloan, E. K. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.18 · Cited by 25
Self-citationGargiulo, L., May, M., Rivero, E. M., Copsel, S. N., Lamb, C. A., Lydon, J. P., Davio, C. A., Lanari, C., Lüthy, I. A., & Bruzzone, A. (2017) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-017-9371-1 · Cited by 23
Dawes, R. P., Burke, K. A., Byun, D. K., Xu, Z., Stastka, P., Chan, L., Brown, E. B., & Madden, K. S. (2020) · Breast Cancer Basic and Clinical Research · doi:10.1177/1178223420931511 · Cited by 24
Colón-Echevarria, C. B., Ortíz, T., Maldonado, L., Hidalgo-Vargas, M. J., Pérez‐Morales, J., Aquino-Acevedo, A. N., Herrera-Noriega, R., Bonilla-Claudio, M., Castro, E., & Armaiz-Peña, G. N. (2020) · Cancers · doi:10.3390/cancers12092671 · Cited by 25
Sandbank, E., Eckerling, A., Margalit, A., Sorski, L., & Ben‐Eliyahu, S. (2023) · Current Oncology · doi:10.3390/curroncol30080540 · Cited by 23
Park, H.-J., Lee, S.-C., & Park, S. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.151087 · Cited by 24
Plavá, J., Buríková, M., Cihova, M., Trnkova, L., Smolková, B., Babál, P., Krivošíková, L., Janega, P., Rojikova, L., Drahošová, S., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02087-2 · Cited by 24
Norepinephrine inhibits the migratory activity of pancreatic cancer cells
Stock, A.-M., Powe, D. G., Hahn, S. A., Troost, G., Niggemann, B., Zänker, K. S., & Entschladen, F. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.04.015 · Cited by 23
Emerging neuroimmune mechanisms in cancer neuroscience
Huang, Y., Zhou, X., Liu, J., Cao, Y., Fu, W., & Yang, J. H. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217492 · Cited by 25
The Impact of Beta Blockers on Survival in Cancer Patients: A Systematic Review and Meta-Analysis
Sharma, A. E., Chan, S., Komorowski, A. S., Cao, X., Gao, Y. K., Kshatri, K., Desai, K., Kuksis, M., Rosen, M. N., Sachdeva, A., et al. (2025) · Cancers · doi:10.3390/cancers17081357 · Cited by 22
Novel approaches to clinical trial design in cancer neuroscience
Jones, G., Anderson, J. L., Nguyen, P. T., Gleber‐Netto, F. O., Hwang, W. L., Puduvalli, V. K., Monje, M., & Amit, M. (2025) · Neuron · doi:10.1016/j.neuron.2025.08.015 · Cited by 24
Remodeling the tumor dormancy ecosystem to prevent recurrence and metastasis
Liang, Y., Chen, W., Zhang, Y., & Li, L. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02328-2 · Cited by 29
“174,175 Chronic stress has been linked to glucocorticoid release through activation of the hypothalamic ‒ pituitary ‒ adrenal (HPA) axis, which subsequently promotes NET formation and induces breast cancer metastasis.”
Role of sympathetic nerves in the establishment of metastatic breast cancer cells in bone
Elefteriou, F. (2016) · Journal of bone oncology · doi:10.1016/j.jbo.2016.03.003 · Cited by 22
Zinnah, K. M. A., & Park, S. (2019) · Anticancer Research · doi:10.21873/anticanres.13877 · Cited by 22
Spotlight on ROS and β 3-Adrenoreceptors Fighting in Cancer Cells
Calvani, M., Subbiani, A., Vignoli, M., & Favre, C. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6346529 · Cited by 24
Interrupting Neuron—Tumor Interactions to Overcome Treatment Resistance
Hunt, P. J., Kabotyanski, K. E., Călin, G. A., Xie, T., Myers, J. N., & Amit, M. (2020) · Cancers · doi:10.3390/cancers12123741 · Cited by 22
Zhong, J., Shan, W., & Zuo, Z. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147280 · Cited by 22
Ieguchi, K., Funakoshi, M., Mishima, T., Takizawa, K., Omori, T., Nakamura, F., Watanabe, M., Tsuji, M., Kiuchi, Y., Kobayashi, S., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810652 · Cited by 22
Haldar, R., Berger, L. S., Rosenne, E., Radin, A. S., Eckerling, A., Sandbank, E., Sloan, E. K., Cole, S. W., & Ben‐Eliyahu, S. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.01.005 · Cited by 22
Self-citationWang, C., Ni, J., Zhai, D., Xu, Y.-C., Wu, Z., Chen, Y., Liu, N., Du, J., Shen, Y., Liu, G., et al. (2024) · Experimental and Molecular Medicine · doi:10.1038/s12276-024-01223-0 · Cited by 23
Liu, J., Zong, G., Zhang, C., Li, C., Chen, X., & Zhang, Y. (2016) · Psycho-Oncology · doi:10.1002/pon.4305 · Cited by 23
Autonomic nervous system control of multiple myeloma
Cheng, Y., Sun, F., D’Souza, A., Dhakal, B., Pisano, M. D., Chhabra, S., Stolley, M. R., Hari, P., & Janz, S. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100741 · Cited by 24
Tumor microenvironment in osteosarcoma: From cellular mechanism to clinical therapy
Yu, Y., Li, K., Peng, Y., Zhang, Z., Pu, F., Shao, Z., & Wu, W. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101569 · Cited by 26
Cancer neuroscience of brain metastasis: When in Rome, do as the Romans do
Karreman, M. A., & Winkler, F. (2025) · Neuron · doi:10.1016/j.neuron.2025.08.003 · Cited by 23
Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
Albiñana, V., Gallardo‐Vara, E., Casado‐Vela, J., Recio-Poveda, L., Botella, L. M., & Cuesta, Á. M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154539 · Cited by 21
Mechanisms Supporting the Use of Beta-Blockers for the Management of Breast Cancer Bone Metastasis
Madel, M., & Elefteriou, F. (2021) · Cancers · doi:10.3390/cancers13122887 · Cited by 25
Murugan, S., Rousseau, B., & Sarkar, D. K. (2021) · Cancers · doi:10.3390/cancers13194858 · Cited by 21
Macrophage heterogeneity and its interactions with stromal cells in tumour microenvironment
Cao, L., Meng, X., Zhang, Z., Liu, Z., & He, Y. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01201-z · Cited by 28
“Sloan et al. observed that the sympathetic nervous system could promote the infiltration of F4/80 + macrophages into tumour sites and induce an M2 phenotype mediated by β-adrenergic signalling [151].”
BackgroundSubclinical cardiac damage in cancer patients before chemotherapy
Fabiani, I., Panichella, G., Aimo, A., Grigoratos, C., Vergaro, G., Pugliese, N. R., Taddei, S., Cardinale, D. M., Passino, C., Emdin, M., et al. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10151-4 · Cited by 21
Zidan, A., Saadany, A. A. E., Maghraby, G. M. E., Abdin, A. A., & Hedya, S. E. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116448 · Cited by 20
Nguyen, T. M., Ngoc, D. T. M., Choi, J., & Lee, C. H. (2023) · Cells · doi:10.3390/cells12151996 · Cited by 22
Survival mechanisms of circulating tumor cells and their implications for cancer treatment
Zhou, S. Y., Xu, H., Duan, Y., Tang, Q., Huang, H., & Bi, F. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10178-7 · Cited by 23
Zhang, J., Deng, Y., Liu, J., Gan, L., & Jiang, Y. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2366451 · Cited by 21
“13,30,45 NE is believed to promote TGF-β1 secretion.”
BackgroundYang, E. V., & Eubank, T. D. (2013) · Cancer Biomarkers · doi:10.3233/cbm-130325 · Cited by 20
“First, evidence from other systems suggests a role for macrophages but the role for these immune cells in mediating stress-associated effects on skin cancer progression in not fully understood and is currently under investigation [42,49].”
Are Beta Blockers New Potential Anticancer Agents?
Akbar, S., & Alsharidah, M. S. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.22.9567 · Cited by 20
Chronic inflammatory states: their relationship to cancer prognosis and symptoms
Macdonald, N. (2011) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2011.315 · Cited by 21
Gronowicz, G., Secor, E. R., Flynn, J. R., & Kuhn, L. T. (2016) · Journal of Chinese Integrative Medicine · doi:10.1016/s2095-4964(16)60275-3 · Cited by 19
Enriched environment inhibits breast cancer progression in obese models with intact leptin signaling
Foglesong, G. D., Queen, N. J., Huang, W., Widstrom, K. J., & Cao, L. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0075 · Cited by 22
Effects of Complementary and Integrative Medicine on Cancer Survivorship
Frenkel, M. A., Sierpina, V. S., & Sapire, K. J. (2015) · Current Oncology Reports · doi:10.1007/s11912-015-0445-1 · Cited by 20
Prognostic significance of β2-adrenergic receptor expression in malignant melanoma
Shimizu, A., Kaira, K., Mori, K. P., Kato, M., Shimizu, K., Yasuda, M., Takahashi, A., Oyama, T., Asao, T., & Ishikawa, O. (2015) · Tumor Biology · doi:10.1007/s13277-015-4420-0 · Cited by 20
The Sympathetic Nervous System Modulates Cancer Vaccine Activity through Monocyte-Derived Cells
Hinkle, L. E., Liu, Y., Meng, C., Chen, Z., Mai, J., Zhang, L., Xu, Y., Pan, P., Chen, S., & Shen, H. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100719 · Cited by 19
Exploring the Role of Metabolites in Cancer and the Associated Nerve Crosstalk
Gu, I., Gregory, E., Atwood, C., Lee, S., & Song, Y. H. (2022) · Nutrients · doi:10.3390/nu14091722 · Cited by 20
The Role of Neural Signaling in the Pancreatic Cancer Microenvironment
Takahashi, R., Ijichi, H., & Fujishiro, M. (2022) · Cancers · doi:10.3390/cancers14174269 · Cited by 23
Tumor microenvironment adrenergic nerves blockade liposomes for cancer therapy
Zhou, S. Y., Li, J., Jiang, Y. Y., Wang, Y., Wang, Z., He, Z., Ouyang, D., Liu, H., & Wang, Y. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.049 · Cited by 21
Profiling the Adrenergic System in Breast Cancer and the Development of Metastasis
Sousa, D. M., Fernandes, V., Lourenço, C., Carvalho‐Maia, C., Estevão‐Pereira, H., Lobo, J., Cantante, M., Couto, M., Conceição, F., Jerónimo, C., et al. (2022) · Cancers · doi:10.3390/cancers14225518 · Cited by 21
Effects of surgical trauma and intraoperative blood loss on tumour progression
Jin, X., Han, H., & Liang, Q. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1412367 · Cited by 19
“These stress responses are mediated by b ARs, which increases the in fi ltration of CD11b + F4/80 + macrophages into the primary tumour parenchyma, thereby inducing M2 macrophage differentiation and prometastatic gene expression (42).”
BackgroundCurrent Therapies and New Targets to Fight Melanoma: A Promising Role for the β3-Adrenoreceptor
Filippi, L., Bruno, G., Domazetovic, V., Favre, C., & Calvani, M. (2020) · Cancers · doi:10.3390/cancers12061415 · Cited by 20
He, R., He, Y., Tang, Y., Zhou, H., McLeod, H. L., & Liu, J. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.152 · Cited by 19
Dynamic interplay of neuroendocrine signaling and immuno-surveillance in tumor niche remodeling
Xu, N., Bian, S., Lyu, P., He, X., & Zheng, W. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104958 · Cited by 20
Hou, T., Ding, H., Huang, G., Meng, T., & Song, D. (2026) · Cellular Oncology · doi:10.1007/s13402-025-01151-9 · Cited by 19
“…the rostral ventrolateral medulla (RVLM), resulting in β-adrenergic receptor (β-AR)-dependent sup - pression of anti-tumor immunity and accelerated breast cancer metastasis (2.5-fold increase in lung nodules); che - mogenetic inhibition of PVN→RVLM circuitry completely reversed these effects [ 4].”
InfluentialThe impact of unplanned reoperations in head and neck cancer surgery on survival
Choi, N., Park, S. I., Kim, H. S., Sohn, I., & Jeong, H. (2018) · Oral Oncology · doi:10.1016/j.oraloncology.2018.06.004 · Cited by 18
The neuro-immune axis in cancer: Relevance of the peripheral nervous system to the disease
Cortese, N., Rigamonti, A., Mantovani, A., & Marchesi, F. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.07.010 · Cited by 17
Lidocaine prevents breast cancer growth by targeting neuronatin to inhibit nerve fibers formation
Li, B., Xu, H. Y., He, C., Zou, W., & Tu, Y. (2021) · The Journal of Toxicological Sciences · doi:10.2131/jts.46.329 · Cited by 18
Reijmen, E., de Mey, S., Damme, H. V., Ridder, K. D., Gevaert, T., Blay, E. D., Bouwens, L., Collen, C., Decoster, L., Couck, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.772555 · Cited by 18
Rousseau, B., Murugan, S., Palagani, A., & Sarkar, D. K. (2022) · Breast Cancer Research · doi:10.1186/s13058-022-01526-y · Cited by 18
Screening of GPCR drugs for repurposing in breast cancer
Abdulkareem, N. M., Bhat, R. R., Powell, R. T., Chikermane, S. G., Yande, S., Trinh, L., Abdelnasser, H. Y., Tabassum, M., Ruiz, A., Sobieski, M. M., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1049640 · Cited by 18
Engineering the Immune Microenvironment into Organoid Models
Luckett, K. A., & Ganesh, K. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-040659 · Cited by 20
Complementary and Integrative Medicine in Lung Cancer: Questions and Challenges
Frenkel, M. A., Slater, R., Sapire, K. J., & Sierpina, V. S. (2018) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2018.0175 · Cited by 18
“61,62 Because most patients are diagnosed with lung cancer in the advanced stage, when the prognosis is poor, the stress and anxiety that these patients experience are quite high.”
Metabolic syndrome and breast cancer: an overview.
Gezgen, G., Roach, E. C., Kızılarslanoğlu, M. C., Petekkaya, İ., & Altundağ, K. (2012) · PubMed · Cited by 18
A Comprehensive Lifestyle Randomized Clinical Trial: Design and Initial Patient Experience
Arun, B., Austin, T., Babiera, G. V., Basen-Engquist, K. M., Carmack, C. L., Chaoul, A., Cohen, L. G., Connelly, L., Haddad, R., Harrison, C. A., et al. (2016) · Integrative Cancer Therapies · doi:10.1177/1534735416679516 · Cited by 18
Self-citationHorváthová, Ľ., & Mravec, B. (2016) · Endocrine Regulations · doi:10.1515/enr-2016-0023 · Cited by 19
Kast, R. E., Skuli, N., Cos, S., Karpel‐Massler, G., Shiozawa, Y., Goshen, R., & Halatsch, M. (2017) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s139963 · Cited by 18
“Beta-adrenergic stimulation did not change the growth of an orthotopic murine breast cancer but did induce a remarkable 30-fold increase in metastases, an effect partially blocked by propranolol.(200) Of clinical importance to ABC7, Shaashua et al(201) showed that combining propranolol with a COX-2 inhibitor in periop…”
Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications
Bucur, O., Stancu, A. L., Khosravi‐Far, R., & Almasan, A. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.2 · Cited by 18
Neurodegeneration of local sympathetic inputs promotes colorectal cancer progression
Chen, X., Cao, Y., Zhao, Y., Ma, Y., Shi, X., Wang, J., Jiang, Z., Luo, R., Deng, Z., Zhou, X., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217817 · Cited by 18
Environmental factors in non‐syndromic orofacial clefts: A review based on meta‐analyses results
Suazo, J. (2021) · Oral Diseases · doi:10.1111/odi.13880 · Cited by 17
Scott, O. W., Tin, S. T., Elwood, M., Cavadino, A., Habel, L. A., Kuper-Hommel, M. J. J., Campbell, I. D., & Lawrenson, R. A. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06528-0 · Cited by 17
Silva, D., Kacprzak, K., Quintas, C., Gonçalves, J., & Fresco, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010767 · Cited by 17
Tumor Neurobiology in the Pathogenesis and Therapy of Head and Neck Cancer
Liang, S., & Heß, J. (2024) · Cells · doi:10.3390/cells13030256 · Cited by 17
“These research tools not only help to elucidate the nature of tumor neurobiology but also facilitate the clinical translation of nerve-specific treatment strategies.”
BackgroundTao, Z.-Y., Wang, L., Zhu, W., Zhang, G., & Su, Y. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0192 · Cited by 17
Cleveland, K. H., Liang, S., Chang, A., Huang, K. M., Chen, S., Guo, L., Huang, Y. S., & Andresen, B. T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217038 · Cited by 17
Regulska, K., Regulski, M., Karolak, B., Michalak, M., Murias, M., & Stanisz, B. J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104326 · Cited by 17
Dragomir, M. P., Moisoiu, V., Manaila, R., Pardini, B., Knutsen, E., Anfossi, S., Amit, M., & Călin, G. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113529 · Cited by 17
Wang, Y., Wang, S., Yang, Q., Li, J., Yu, F., & Zhao, E. (2021) · Journal of Immunology Research · doi:10.1155/2021/5580672 · Cited by 17
Wang, W., He, Q., Zhang, H., Zhuang, C., Wang, Q., Li, C., Sun, R., Fan, X., & Yu, J. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-2133 · Cited by 18
Neural control of tumor immunity
Kizil, B., Virgiliis, F. D., & Scheiermann, C. (2024) · FEBS Journal · doi:10.1111/febs.17280 · Cited by 16
Chen, Y., Qian, Y., Huang, W., Zhang, Y., Wu, M., Cheng, Y., Yang, N., & Liu, Y. (2022) · PubMed Central · Cited by 16
Social Isolation and Breast Cancer
Hilakivi-Clarke, L. A., & Andrade, F. D. O. (2023) · Endocrinology · doi:10.1210/endocr/bqad126 · Cited by 22
Le, C. P., Karnezis, T., Achen, M. G., Stacker, S. A., & Sloan, E. K. (2013) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2013.10.008 · Cited by 15
“Of potential clinical importance, beta-blockers prevented metastasis suggesting a novel avenue for therapeutic intervention [20, 21, 24, 27, 31].”
InfluentialSelf-citationSignaling Pathways in Thyroid Cancer
Jin, S., Yang, Y., & Bao, W. (2017) · Vitamins and hormones · doi:10.1016/bs.vh.2017.05.002 · Cited by 16
Advising Women Undergoing Treatment for Breast Cancer: A Narrative Review
Lemanne, D., & Maizes, V. H. (2018) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2018.0150 · Cited by 16
“69,70 Whether stress reduction improves breast cancer survival is unknown; however, quality of life is improved with use of stress management interventions.”
Implication of Spiritual Network Support System in Epigenomic Modulation and Health Trajectory
Holmes, L., Chinaka, C., Elmi, H., Deepika, K., Pelaez, L., Enwere, M., Akinola, O., & DABNEY, K. W. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16214123 · Cited by 18
Truong, L.-L., Scott, L. J., Pal, R., Jalink, M., Gunasekera, S., & Wijeratne, D. T. (2022) · ecancermedicalscience · doi:10.3332/ecancer.2022.1430 · Cited by 15
Expression of β-adrenergic receptors in pediatric malignant brain tumors
Sardi, I., Giunti, L., Bresci, C., Buccoliero, A. M., Degl’Innocenti, D. R., Cardellicchio, S., Baroni, G., CASTIGLIONE, F., Ros, M. D., Fiorini, P., et al. (2012) · Oncology Letters · doi:10.3892/ol.2012.989 · Cited by 16
“A recent study revealed that β -adrenergic signaling may also play a role in the growth and metastatic dissemination in an orthotopic mouse model of breast cancer (9).”
Kafetzopoulou, L. E., Boocock, D. J., Dhondalay, G. K., Powe, D. G., & Ball, G. (2013) · Computational and Structural Biotechnology Journal · doi:10.5936/csbj.201303003 · Cited by 16
Nanotechnology Meets the Tumor Microenvironment: Unlocking New Horizons in Cancer Therapy
Yadav, P., Yadav, A. K., & Bhatia, D. D. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c01120 · Cited by 16
The neuroimmune axis in breast cancer: from mechanistic insights to clinical applications
Wu, Y., Zhang, K., 夏新亚, Zhang, T., Jiang, N., Zhang, Y., Zheng, F., Jiang, Y., Xiang, X., Miao, H., et al. (2026) · BMC Medicine · doi:10.1186/s12916-026-04870-4 · Cited by 15
“…macrophages by blocking β-AR to exert antitumor effects, but its blockade of β2-AR in vascular smooth muscle may affect peripheral vascular regulation, exacerbating the contradiction between toxicity and efficacy caused by the accumulation of exposure during systemic administration [67, 208, 235].”
A role for cAMP-driven transactivation of EGFR in cancer aggressiveness – Therapeutic implications
McCarty, M. F. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.05.009 · Cited by 15
“Psychological stressors, nicotine administration, or continual infusion of norepinephrine have been shown to accelerate the growth or spread of certain cancers in rodents, and this effect can be blocked with propranolol or other beta2 antagonists.(30;36;93-100) Likewise, exposure of many cancer cell lines to adrenergi…”
McCaffrey, D., Lawther, A. J., Weickert, C. S., & Walker, A. K. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105938 · Cited by 16
Goel, N., Hernandez, A. E., Antoni, M. H., Kesmodel, S. B., Pinheiro, P. S., Kobetz, E. N., Merchant, N. B., & Cole, S. W. (2024) · Annals of Surgery · doi:10.1097/sla.0000000000006283 · Cited by 15
“19,33 Importantly, we discovered that these TF patterns correlate with more worse clinical features such as high-risk Oncotype DX scores and shorter RFS, validating their association with clinically relevant aggressive biology.”
BackgroundSelf-citationWang, Y., Anesi, J., Panicker, I. S., Cook, D., Bista, P., Fang, Y., & Oqueli, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062553 · Cited by 16
Chronic stress, sympathetic activation and skeletal metastasis of breast cancer cells
Elefteriou, F. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.61 · Cited by 15
Household Income Is Associated with the p53 Mutation Frequency in Human Breast Tumors
Starks, A. M., Martin, D. N., Dorsey, T. H., Boersma, B. J., Wallace, T. A., & Ambs, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057361 · Cited by 16
Jin, J., Miao, C., Wang, Z., Zhang, W., Zhang, X., Xie, X., & Lu, W. P. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.03.032 · Cited by 15
Wu, J., Yang, Y., Peng, W.-T., Sun, J.-C., Sun, W., & Wei, W. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s209291 · Cited by 16
“A previous study demonstrated that β-adrenergic signaling modulates the growth and metastasis of tumors by producing changes to the tumor microenvironment, including macrophage recruitment.(12) Grailer et al(13) reported that catecholamine-induced activation of the β2-AR modified the entire macrophage phenotype, resul…”
Surgery and cancer promotion: are we trading beauty for cancer?
Goldstein, M. R., & Mascitelli, L. (2011) · QJM · doi:10.1093/qjmed/hcr039 · Cited by 15
Metadata
- Authors
- Sloan, E. K., Priceman, S. J., Cox, B. F., Yu, S., Pimentel, M. A., Tangkanangnukul, V., Arevalo, J. M. G., Morizono, K., Karanikolas, B. D. W., Wu, L., Sood, A. K., & Cole, S. W.
- Affiliations
- University of California, Los Angeles (US)
- Authors' Affiliations: 1UCLA Norman Cousins Center at the Semel Institute for Neuroscience and Human Behavior, Department of Medicine, 2Division of Hematology-Oncology, UCLA School of Medicine, UCLA AIDS Institute, 3Jonsson Comprehensive Cancer Center, 4UCLA Department of Molecular and Medical Pharmacology, and 5UCLA Molecular Biology Institute, Los Angeles, California; and 6Departments of Gynecologic Oncology and Cancer Biology, M.D. Anderson Comprehensive Cancer Center, Houston, Texas
- Corresponding author
- Sloan, Erica K.
- ORCID
- Venue
- Cancer Research
- Published
- 2010-09-14
- Volume
- 70
- Issue
- 18
- Pages
- 7042-7052
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC2940980
- OpenAlex
- W2107567947
- Cited by
- 930
- References
- 53
- Citations by year
- 2026: 97 · 2025: 76 · 2024: 72 · 2023: 63 · 2022: 78 · 2021: 94 · 2020: 59 · 2019: 65 · 2018: 42 · 2017: 40 · 2016: 45 · 2015: 50 · 2014: 38 · 2013: 49 · 2012: 32
- FWCI
- 23.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA 109298, R01CA110793, CA 110793, R01CA109298, R01CA116778, CA-116778, R21CA138687, CA138687, R01CA160890)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- breast cancer metastasis, sympathetic nervous system, neuroendocrine activation, stress, beta-adrenergic signaling, tumor-associated macrophages, M2 macrophage polarization, propranolol, GW2580, lymph node metastasis, lung metastasis, orthotopic mouse model, anti-metastatic therapy
- MeSH terms
- Adenocarcinoma, Animals, Female, Macrophages, Mammary Neoplasms, Experimental, Mice, Inbred BALB C, Mice, Nude, Neoplasm Metastasis, Stress, Physiological, Sympathetic Nervous System, T-Lymphocytes, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
